Anti-Human CLDN6 & CD137 Bispecific Antibody (BPDNX240) is a research-grade recombinant antibody targeting CD137. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.